Clinical Evaluation of Orion Lamina Cover in Patients Undergoing Lumbar Laminectomy With Instrumented Fusion
1 other identifier
interventional
30
1 country
1
Brief Summary
Laminectomy with internal fixation and osseofusion is a common surgery for treating degenerative spinal diseases. It removes excessive bone spurs and removes the lamina for decompression to relieve nerve compression, and then utilizes a spinal fixation system to stabilize the structure to relieve lower limb pain, paralysis, and other symptoms. However, the spinal cord that lacks lamina coverage after surgery is often compressed by scar tissue formation and hematoma, leading to postoperative back and lower limb pain. Therefore, this trial is divided into two groups, comparing the use of the cross connector of the ORION spinal system - the spinal lamina cover and the general spinal fixation system (without lamina cover). For participants undergoing laminectomy with internal fixation and osseofusion, after utilizing the spinal lamina cover of the ORION spinal system, whether the nerve compression caused by postoperative scar tissue formation and hematoma can be effectively reduced, and the pain in the back and lower limbs can be improved.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 22, 2024
CompletedFirst Submitted
Initial submission to the registry
July 30, 2024
CompletedFirst Posted
Study publicly available on registry
August 1, 2024
CompletedAugust 1, 2024
July 1, 2024
2.1 years
July 30, 2024
July 30, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Magnetic Resonance Imaging (MRI)
To observe the recovery of the participants' spine
Six months after surgery
Visual Analogue Scale (VAS)
To measure the pain and numb of the participants' back and limbs
Pre-surgery; one month after surgery; three months after surgery; six months after surgery
Secondary Outcomes (2)
Oswestry Disability Index (ODI)
Pre-surgery; one month after surgery; three months after surgery; six months after surgery
Sort Form-12 Health Survey (SF-12)
Pre-surgery; one month after surgery; three months after surgery; six months after surgery
Study Arms (2)
Control group
SHAM COMPARATORGeneral spinal system
LMC group
EXPERIMENTALGeneral spinal system with ORION spinal lamina cover
Interventions
Eligibility Criteria
You may qualify if:
- Gender and age: females and males are at least 20 years old
- Who with degenerative lumbar spondylolisthesis in one or two consecutive segments from lumbar vertebra L1 to sacral vertebra S1, and have objective evidence of back pain and numbness radiating to the lower limbs.
- Clinical symptoms of degenerative lumbar spondylolisthesis, accompanied by objective symptoms of neurological deficit; spinal stenosis, neurogenic claudication or bilateral radiating pain.
- Have received at least 3 months of non-surgical treatment without effectiveness.
- Radiographic examination was consistent with clinical symptoms of degenerative spondylolisthesis or spinal stenosis.
- After diagnosis who needs laminectomy with internal fixation and osseofusion
- Able and willing to sign the consent form and answer the questionnaire.
You may not qualify if:
- Already had lumbar surgery at the same lumbar vertebra
- Physically health not well
- Probably pregnant
- Who suffering from malignant tumors or infections
- below 20 years old
- Unable and unwilling to answer the questionnaire and return to the hospital for treatment
- Unable to undergo MRI examination due to any reason, such as having a cardiac rhythm regulator, ferromagnetic implants, or claustrophobia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Orion Biotech Inc.lead
- Taipei Veterans General Hospital, Taiwancollaborator
Study Sites (1)
Taipei Veterans General Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yu-Cheng Yao
Taipei Veterans General Hospital, Taiwan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2024
First Posted
August 1, 2024
Study Start
March 30, 2022
Primary Completion
May 22, 2024
Study Completion
May 22, 2024
Last Updated
August 1, 2024
Record last verified: 2024-07